non-nucleoside analog RNA-dependent RNA polymerase inhibitors (Janssen)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namenon-nucleoside analog RNA-dependent RNA polymerase inhibitors (Janssen)
Drug Alias NameRNA-dependent RNA polymerase inhibitors (Alios)non-nucleoside analog RNA-dependent RNA polymerase inhibitors (Alios)RNA-dependent RNA polymerase inhibitors (Janssen)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBacterial DNA-directed RNA polymerase inhibitors
TargetsBacterial DNA-directed RNA polymerase
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlios Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJanssen Pharmaceuticals IncAlios Biopharma Inc
Active IndicationsN/A
Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A
Related LinksN/A